Literature DB >> 17333064

[Cardiac MR imaging in arrhythmogenic heart diseases].

C K Böhm1, T Papavassiliu, D J Dinter, S J Diehl, M Borggrefe, K W Neff.   

Abstract

INTRODUCTION: Cardiac arrhythmias are assessed with a combination of history, clinical examination, electrocardiogram, Holter monitor, if necessary supplemented by invasive cardiac electrophysiology. In ischemic heart disease (IHD) coronary angiography is performed in addition.
METHODS: Echocardiography is usually the primary imaging modality. MRI is increasingly recognized as an important investigation allowing more accurate cardiac morphological and functional assessment.
RESULTS: Approximately one-fifth of deaths in Western countries are due to sudden cardiac death, 80% of which are caused by arrhythmias. Typical causes range from diseases with high prevalence (IHD in men 30%) to myocarditis (prevalence 1-9%) and rare cardiomyopathies (prevalence HCM 0.2%, ARVC 0.02%, Brugada syndrome approx. 0.5%). The characteristic MRI features of arrhythmogenic diseases and the new aspects of characteristic distribution of late enhancement allow etiologic classification and differential diagnosis.
CONCLUSION: MRI represents an important tool for detection of the underlying cause and for risk stratification in many diseases associated with arrhythmias.

Entities:  

Mesh:

Year:  2007        PMID: 17333064     DOI: 10.1007/s00117-007-1487-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  33 in total

1.  Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy.

Authors:  O Strohm; J Schulz-Menger; B Pilz; K J Osterziel; R Dietz; M G Friedrich
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

2.  Magnetic resonance imaging findings in patients with Brugada syndrome.

Authors:  Theano Papavassiliu; Christian Wolpert; Stephan Flüchter; Rainer Schimpf; Wolfgang Neff; Karl Konstantin Haase; Christoph Düber; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2004-10

3.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

Review 5.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

Review 6.  Arrhythmogenic right-ventricular dysplasia/cardiomyopathy.

Authors:  Hugh Calkins
Journal:  Curr Opin Cardiol       Date:  2006-01       Impact factor: 2.161

7.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

8.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

9.  [Determining myocardial viability in myocardial infarct. Comparison of single and multisclice MRI techniques with TurboFlash and TrueFISP sequences].

Authors:  A Huber; S O Schönberg; B Spannagl; J Rieber; V Klauss; M F Reiser
Journal:  Radiologe       Date:  2004-02       Impact factor: 0.635

Review 10.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

View more
  1 in total

Review 1.  Cell models of arrhythmogenic cardiomyopathy: advances and opportunities.

Authors:  Elena Sommariva; Ilaria Stadiotti; Gianluca L Perrucci; Claudio Tondo; Giulio Pompilio
Journal:  Dis Model Mech       Date:  2017-07-01       Impact factor: 5.758

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.